SEC FORM 4
$205,790.86
UNITED THERAPEUTICS Corp (UTHR)
Sale of 380 shares at $541.5549 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 6, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →